Company
K2
A scalable hub-and-spoke engine for global drug development
Also known as K2 Therapeutics, Inc
- Business model
- B2B
- Legal name
- K2 Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
K2 Therapeutics is a biotech company built for global impact, with search and development capabilities unconstrained by modality or geography. We identify the world’s most innovative assets and translate them into great medicines through a disciplined development approach and lead by experienced drug developers. Our focus is on high-potential first- and best-in-class assets with meaningful potential for patient impact worldwide.
Funding snapshot
- Total raised
- $349MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $240M2024-04-24
Funding rounds
- Round, 2024
- $240M2024-04-24, SEC form D sold, 7 investors
- Round, 2019
- $9M2019-09-03, SEC form D sold, 1 investor
- Round, 2018
- $1.6M2018-05-23, SEC form D sold, 16 investors
- Round, 2017
- $20.2M2017-10-24, SEC form D sold, 16 investors
- Round, 2015
- $42M2015-02-10, SEC form D sold, 19 investors
- Round, 2014
- $6M2014-05-30, SEC form D sold, 1 investor
- Round, 2014
- $30.3M2014-05-30, SEC form D sold, 8 investors
Products
- Web
- KTT-001
Loading relationship preview